A randomised, placebo-controlled, double-blind study to evaluate the effect of SAGE-718 on cognitive function in participants with Huntington's Disease (2022-2024)
Experts
Dr
Rob Adam
Trials Medical Specialist
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
